Literature DB >> 10338126

Characterization of a soluble class I alpha-mannosidase in human serum.

S Porwoll1, H Fuchs, R Tauber.   

Abstract

Class I alpha-mannosidases are thought to exist exclusively as integral membrane proteins that play intracellulary an essential role in the N-glycan biosynthesis. Using [3H]Man9GlcNAc2 as a substrate, we were able to identify a soluble alpha-mannosidase in human serum that trims the substrate Man9GlcNAc2 to Man(5-8)GlcNAc2 with Man6GlcNAc2 being the major product. This serum mannosidase is Ca2+-dependent, sensitive to 1-deoxymannojirimycin but insensitive to the class II inhibitor swainsonine and, hence, belongs to class I mannosidases. The enzymatic properties of the serum class I mannosidase are similar to that of the membrane bound class I mannosidases Golgi-mannosidase IA and IB and Man9-mannosidase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10338126     DOI: 10.1016/s0014-5793(99)00422-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans.

Authors:  Marcella Yu; Darren Brown; Chae Reed; Shan Chung; Jeff Lutman; Eric Stefanich; Anne Wong; Jean-Philippe Stephan; Robert Bayer
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

Review 2.  Regulation of intracellular signaling by extracellular glycan remodeling.

Authors:  Randy B Parker; Jennifer J Kohler
Journal:  ACS Chem Biol       Date:  2010-01-15       Impact factor: 5.100

3.  Synthetic Neoglycoconjugates of Hepta- and Nonamannoside Ligands for Eliciting Oligomannose-Specific HIV-1-Neutralizing Antibodies.

Authors:  Matteo Cattin; Jean-François Bruxelle; Kurtis Ng; Markus Blaukopf; Ralph Pantophlet; Paul Kosma
Journal:  Chembiochem       Date:  2022-02-11       Impact factor: 3.461

4.  A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins.

Authors:  Weichen Xu; Rod Brian Jimenez; Rachel Mowery; Haibin Luo; Mingyan Cao; Nitin Agarwal; Irina Ramos; Xiangyang Wang; Jihong Wang
Journal:  MAbs       Date:  2017-08-14       Impact factor: 5.857

5.  Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities.

Authors:  Dung N Nguyen; Bokai Xu; Robyn L Stanfield; Jennifer K Bailey; Satoru Horiya; J Sebastian Temme; Deborah R Leon; Celia C LaBranche; David C Montefiori; Catherine E Costello; Ian A Wilson; Isaac J Krauss
Journal:  ACS Cent Sci       Date:  2019-02-06       Impact factor: 14.553

6.  The Impact of Sustained Immunization Regimens on the Antibody Response to Oligomannose Glycans.

Authors:  Dung N Nguyen; Richard L Redman; Satoru Horiya; Jennifer K Bailey; Bokai Xu; Robyn L Stanfield; J Sebastian Temme; Celia C LaBranche; Shiyu Wang; Avital A Rodal; David C Montefiori; Ian A Wilson; Isaac J Krauss
Journal:  ACS Chem Biol       Date:  2020-03-09       Impact factor: 5.100

7.  Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies.

Authors:  Jean-François Bruxelle; Tess Kirilenko; Quratulain Qureshi; Naiomi Lu; Nino Trattnig; Paul Kosma; Ralph Pantophlet
Journal:  Sci Rep       Date:  2020-05-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.